The Ladies Auxiliary to the Veterans of Foreign Wars (VFW), Department of West Virginia, has donated more than $3,300 to the West Virginia University Cancer Institute for breast cancer research.
“I wanted the money to go to breast cancer because it can effect both men and women,” said Corley, who lost one brother to cancer and has another brother currently undergoing cancer treatment. Corley, from VFW Post 410 in Belington, said all 58 ladies auxiliaries in West Virginia raised the money through basket raffles and bake sales.
For more than two decades the organization's WV membership has supported the WVU Cancer Institute, and with the latest gift has raised more than $170,000 for research efforts.
For information on the Ladies Auxiliary to the Veterans of Foreign Wars, Department of West Virginia, visit http://www.ladiesauxvfw.org/post_cards/west-virginia/.
For information on the WVU Cancer Institute Breast Cancer Research Program, visit http://wvucancer.org/Research/Programs/cbcp.
The WVU Cancer Institute is the first institution in the United States to offer intraoperative radiation therapy (IORT) to treat glioblastoma.
Several events at this year’s West Virginia Writers’ Workshop, July 20-23 at WVU, are focused on the role of writing and storytelling in health. Presenters include narrative medicine faculty from several campuses across the U.S., along with the leaders of an expressive writing program for patients at the WVU Cancer Institute. Health sciences faculty, staff and students are invited to participate in some or all of the Workshop.
WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.